GGrantIndex
Sort

23,748 grants matching melanoma

Genome amplification and dysbiosis in tongue cancer

$237,750
Donna G Albertson · New York University · R21 · FY2018 · DE

Regulation of T cell exhaustion by microRNA-720

$237,750
You-Wen He · Duke University · R21 · FY2015 · AI

E2F-1 Cancer Gene Therapy

$237,741
University Of Louisville · R01 · FY2002 · CA

Transcriptional Regulation of Melanocyte Development

$237,738
Henry Ford Health System · R01 · FY2004 · AR

Transcriptional Regulation of Melanocyte Development

$237,738
Henry Ford Health System · R01 · FY2001 · AR

Transcriptional Regulation of Melanocyte Development

$237,738
Henry Ford Health System · R01 · FY2002 · AR

Role of IDO in Malignancy

$237,738
Medical College Of Georgia (Mcg) · R01 · FY2005 · CA

Role of IDO in Malignancy

$237,738
Medical College Of Georgia (Mcg) · R01 · FY2003 · CA

Role of IDO in Malignancy

$237,738
Medical College Of Georgia (Mcg) · R01 · FY2004 · CA

A germline variant that predicts and modulates the response of melanoma to immunotherapy

$237,724
Iman Osman · New York University School Of Medicine · R21 · FY2018 · CA

Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapy

$237,724
Dennis L. Kasper · Harvard Medical School · R21 · FY2024 · CA

Novel targets of treatment for NF1-mutant melanoma

$237,724
Iman Osman · New York University School Of Medicine · R21 · FY2021 · CA

TERT epigenetic and genomic variants in stage II melanoma as biomarkers of outcome

$237,724
David Polsky · New York University School Of Medicine · R21 · FY2023 · CA

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis

$237,724
Melody Y Zeng · Weill Medical Coll Of Cornell Univ · R21 · FY2023 · CA

Metabolic adaptations in melanoma brain metastasis

$237,724
Eva Hernando · New York University School Of Medicine · R21 · FY2025 · CA

Modulating extracellular TCR-CD3 interactions to identify new melanoma immunotherapy targets

$237,724
Aswin Natarajan · New York University School Of Medicine · R21 · FY2021 · CA

Role of Filamin A in Inflammation and Oncogenesis

$237,690
Michel Bernier · National Institute On Aging · ZIA · FY2009 · AG

A New Strategy for Targeted Chemoimmunotherapy of Cancer

$237,642
University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA

Cytokine Induced Depression

$237,616
Andrew H Miller · Emory University · U19 · FY2007 · MH

Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine

$237,514
Susan Dana Jones · Immurx Llc · R43 · FY2011 · AI

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

$237,507
Levi Alexander Garraway · Dana-Farber Cancer Inst · P50 · FY2013 · CA

REGULATION OF EXPRESSION OF MGSA/GRO GENES IN MELANOMA

$237,416
Vanderbilt University · R01 · FY2000 · CA

Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch

$237,407
Itzhak Avital · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells

$237,407
Itzhak Avital · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Regulation of Metastasis and Angiogenesis by Autotaxin and its Products

$237,348
Mary Stracke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA